CAVA Group, Inc., is rated a Hold due to its elevated valuation relative to peers and sector benchmarks. Learn more about ...

Biogen said on Friday it has gained global rights to privately held Vanqua Bio's experimental drug for up to $1.06 billion to ...

Early voting is already underway in the Virginia governor's race where voters will pick a replacement for Republican Gov.

Washington — Much of the federal government shut down Wednesday, October 1, after Congress failed to reach a deal to approve new funding. Republicans had proposed extending government funding at ...

C5aR1 plays an important role in the immune cascade that causes tissue inflammation, particularly in neutrophil-mediated conditions. There’s an obvious overlap with Biogen’s own izastobart, an ...

The Cavaliers (6-1, 3-0) are one of three ACC squads unbeaten in conference play. Here’s what you need to know about UNC’s ...

Our writers analyse and evaluate the key talking points from Chelsea's resounding victory over Ajax at home in the Champions ...

The anti-CD20 antibody, developed by Roche’s Genentech along with Biogen and already approved for multiple oncology indications, is branching into autoimmune disease. Its B cell–targeting mechanism of ...

Alkermes plc (Nasdaq: ALKS) ("Alkermes") and Avadel Pharmaceuticals plc (Nasdaq: AVDL) ("Avadel") today announced that the companies have entered into a definitive agreement under which Alkermes will ...

The drug is the only medicine of its kind proven to help patients with lupus nephritis regain full kidney response, the ...

Under FDA regulations, suspension is not the end of the process. Unless a license holder voluntarily relinquishes its license ...

Carvana (CVNA) closed the most recent trading day at $337.60, moving +1.14% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 1.07%. Elsewhere, the ...